Galectin-3 as a Prognostic Biomarker in Patients with First Acute Myocardial Infarction without Heart Failure

Background: Galectin-3 (Gal-3) is a biomarker involved in a wide range of diseases including cardiac remodeling following acute myocardial infarction (AMI). Identification of prognostic markers in patients with AMI can guide strategies towards improved survival and quality of life. Methods: Our stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Vucic, Rada M., Andrejic, Olivera M., Stokanovic, Dragana, Stoimenov, Tatjana Jevtovic, McClements, Lana, Nikolic, Valentina N., Sreckovic, Miodrag, Veselinovic, Mirjana, Aleksandric, Srdjan, Popadic, Viseslav, Zdravkovic, Marija, Pavlovic, Milan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647840/
https://www.ncbi.nlm.nih.gov/pubmed/37958244
http://dx.doi.org/10.3390/diagnostics13213348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647840/
https://www.ncbi.nlm.nih.gov/pubmed/37958244
http://dx.doi.org/10.3390/diagnostics13213348

Ejemplares similares